Rituximab Seems Safe and Effective for Systemic Sclerosis

NEW YORK (Reuters Health) – Rituximab seemed to be a safe and effective treatment for systemic sclerosis in a placebo-controlled validation trial in Japan. “A number of studies have examined B-cell depletion therapy for systemic sclerosis, and many of them have suggested that (this) is effective in treating systemic sclerosis,”…